Reduction of thymic weight and size as well as ectopic development of adipocytes in thymus from rats administered cocaine for 14 days. by Kana Unuma (283272)

Differential subcellular localization of wild-type and mutant BMPR2. by Hu Wang (46407)

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

PRL decreases anterior pituitary cell proliferation <i>in vivo</i>. by Jimena Ferraris (314722)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Iminosugar-based GCS inhibitors decrease brain GFAP positive cells. by Karen M. Ashe (349018)

Iminosugar-based GCS inhibitors decrease brain α-synuclein aggregates. by Karen M. Ashe (349018)

Schematic diagram of STTFP model. by Guozhu Sui (21672798)

Top twenty genes with most significant local associations. by Wei Chen (23863)

IL-1β targeted vaccine (1βEPP) elicits relatively high antibody responses, decreases body weight gain, and protects from hyperglycemia in KK-A^y mice. by Jun Zha (2735284)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Zinc exposure attenuates NR2A clusters and currents. by Jia Zhu (135506)

“…Both the number and mean intensity of NR2A clusters significantly decreased after zinc treatment. …”

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

MSC-EVs decrease epithelial cell inflammation and improve cell health. by Caryn Cloer (351721)

Expression of FASN in human glioblastoma cells and GSC lines. by Yuki Yasumoto (685821)

Supplementary Material for: Sputum Eicosanoid Profiling in Exacerbations of Chronic Obstructive Pulmonary Disease by Drozdovszky O (4144243)

“…<b><i>Objectives:</i></b> The aim of this study was to investigate changes in leukotriene B₄ (LTB₄), 8-isoprostane, prostaglandin E₂ (PGE₂) and cysteinyl-leukotriene (cys-LT) levels in the sputum of patients with chronic obstructive pulmonary disease (COPD) at the onset of a severe exacerbation and during the course of recovery. …”